-
The Gainesville Sun - 1 hour 38 minutes ago
The Associated Press Federal health regulators are investigating reports of dangerous radiation levels at two more California hospitals, following earlier unsafe medical scans at a Los Angeles facility.
-
EurekAlert! - Mon Dec 7, 1:28 pm ET
( American Psychological Association ) People who drink may want to know that coffee won't sober them up, according to new laboratory research. Instead, a cup of coffee may make it harder for people to realize they're drunk.
-
Nasdaq - Mon Dec 7, 1:17 pm ET
NEW YORK -(Dow Jones)- Celgene Corp. (CELG) agreed to acquire privately held Gloucester Pharmaceuticals Inc. for $340 million plus milestone payments of up to $300 million in a deal to bolster its position in blood cancer treatments.
-
The Record and Herald News - Mon Dec 7, 1:04 pm ET
The deal includes $340 million in cash upfront and $300 million in future regulatory milestone payments.
-
Boston Herald - Mon Dec 7, 12:49 pm ET
WASHINGTON - Federal health regulators have identified 50 more patients exposed to dangerous radiation levels from brain scans at a hospital in Los Angeles. The Food and...
-
The Oregonian - Mon Dec 7, 12:38 pm ET
The recall covers Brooklyn's Best brand Smoked Nova Salmon, which was sold in Portland and elsewhere in the country.
-
Nasdaq - Mon Dec 7, 12:18 pm ET
A Medtronic Inc. (MDT) brain-stimulation device showed mounting benefits over time by leading to fewer seizure episodes for epilepsy patients, according to long-term results from a company-funded study examining the technology.
-
KHON 2 Honolulu - Mon Dec 7, 4:25 pm ET
Today marks the 68th anniversary of the Japanese attack on Pearl Harbor . This morning, Pearl Harbor survivors, World War II Veterans and others gathered to reflect, remember and show gratitude for the thousands who lost their lives that day.
-
Fox News - Mon Dec 7, 3:05 am ET
Elan: J&J Unit Seeks Europe Schizophrenia-drug OK
-
EurekAlert! - Mon Dec 7, 11:35 am ET
( University of Texas M. D. Anderson Cancer Center ) Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at the University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.
-
socalTech.com - Mon Dec 7, 8:54 am ET
San Diego-based Somaxon Pharmaceuticals, a developer of a drug for the treatment of insomnia, reported this morning that it has received a response from the U.S. Food and Drug Administration on its NAD for Silenor, the firm's treatment of insomnia. The firm said that the Complete Response Letter from the FDA said that based on its review, the FDA has determined that Somaxon's NDA cannot be ...
-
St. Petersburg Times - Mon Dec 7, 10:39 am ET
How concerned should I be about the federal warning regarding oysters?
-
KENS 5 San Antonio - Mon Dec 7, 3:05 pm ET
The U.S. government are warning consumers to avoid oysters from San Antonio Bay in Texas after investigators found the oysters caused a highly contagious virus. The U.S. government has warned consumers to avoid oysters from San Antonio Bay in Texas after investigators found the oysters caused a highly contagious virus. Consumers who bought San Antonio Bay-harvested oysters on or after November ...
-
redOrbit - Sun Dec 6, 11:08 pm ET
Consumers advised to avoid oysters harvested from San Antonio Bay SILVER SPRING, Md., Dec. 6 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is advising consumers to avoid eating oysters harvested from the San Antonio Bay on or after Nov.
-
EurekAlert! - Mon Dec 7, 10:03 am ET
( GCI Health ) Biogen Idec today announced that its oral compound BG-12 achieved key milestones in clinical trials for multiple sclerosis (MS) and rheumatoid arthritis (RA). In recent months, the last patient was enrolled in the CONFIRM trial, the second of two Phase III trials designed to evaluate the efficacy and safety of BG-12 as a monotherapy in patients with relapsing-remitting multiple ...